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Introduction
Clinical thyroid cancer is uncommon, with an esti-
mated incidence in various parts of the world of 0.5 to 10
cases per 100,000 persons.1 It accounts roughly for about
0.5% of all cancers in men and 1.5% of all cancers in
women.2 It is however the most common endocrine tumor
and may present either as a solitary nodule in the setting of
an entirely normal thyroid gland or, as a dominant nodule in
the setting of a multinodular goiter. Five to 6.5% of nodular
thyroid are found to be neoplastic.3-5
In Pakistan thyroid cancer is responsible for 1.2%
cases of all malignant tumors.6 Previous reports from this
region show papillary thyroid cancer to constitute 57 to 89%
of all thyroid malignancies.6-8 The female to male ratio in
this part of the world is noted to be between 2.5 to 4:1,
which is comparable to international data. No information is
available regarding its mode of presentation and clinical
characteristics in Pakistan.
Patients and Methods
A retrospective chart review was conducted of all
those patients that underwent partial or total thyroidectomy
between 1989 and 2002 at Aga Khan University Hospital
(AKUH), Karachi. These patients were operated upon by
either general or ENT surgeons. All those found to have thy-
roid cancer proven on pre-operative cytology and/or post
operative histopathology were included in the study. The
patients who underwent thyroidectomy for Graves disease
or toxic multinodular goiter were excluded, unless the
histopathology showed presence of incidental thyroid carci-
noma. Information regarding demographic characteristics,
presenting symptoms, past history of radiation exposure,
family history of thyroid cancer, preferred initial diagnostic
work-up, histopathology, presence of local and/or distant
metastases and initial surgical procedure was gathered. The
clinical description of the thyroid was noted from pre-oper-
ative physical examination notes. The thyroid gland was
noted to have a "single nodule" when this notation was
recorded as such. Multiple nodules bilaterally or "large goi-
ter" was noted as a multinodular gland. Thyroid "mass" was
deemed to indicate a large lobe that was asymmetric, and
therefore recorded as an asymmetric "goiter". An attempt
was also made to access post-operative follow-up care;
however this data was scanty and therefore not included in
the final analysis. SPSS was used to analyze the data and
Pearson's chi-square and likelihood ratios used to calculate
significance.
Results
A total of 97 patients were included in this review.
The peak incidence was seen in 30 to 60 year age group,
with a female to male ratio of 2.2:1.The symptoms at pres-
entation are shown in Figure.                                 
Majority of the patients presented either with a "thy-
roid mass" in the anterior neck (31%) or with an increase in
the size of a long standing goiter (27.8%). Solitary thyroid
nodule was the presentation in only 3 patients, and hyper-
thyroidism was an associated presentation in 2 others.
Hoarseness, dysphagia and shortness of breath were seen in
less than 5% at the time of presentation. Size of the tumor
was documented in two thirds of the patients either at the
time of clinical evaluation or pathologic reporting. Of these
58 patients, 42 (72%) had a primary tumor of over 3 cm in
Clinical Presentation of Thyroid Cancer Patients in Pakistan - AKUH Experience
L. M. Zuberi, A. Yawar, N. Islam, A. Jabbar
Department of Medicine, Aga Khan University Hospital, Karachi.
Abstract
Objective: To asses the clinical presentation of patients with thyroid cancer, their preferred diagnostic work-up
and preferred surgical procedure. 
Methods: A retrospective chart review of patients that underwent partial or total thyroidectomy for thyroid can-
cer at AKUH between 1989 and 2002. SPSS was used to analyze data. Pearson's chi square and likelihood
ratios used to calculate tests of significance.
Results: A total of 97 patients were included in this review. Solitary thyroid nodule was the initial presentation in
three. Majority (58.7%) presented with "neck swelling" or enlarging goiter. One out of every 3 patients showed
evidence of lymph node involvement and 20% had distant metastases. The aggressiveness of the disease did
not correlate with age, sex or histological subtype. There was no correlation between the size of the tumor and
presence of local or distant metastases.
Conclusion: Thyroid cancer is a more aggressive disease in Pakistan, with majority of patients presenting with
multinodular goiters, and a significant number have lymph node metastases. A higher degree of vigilance and a
lower threshold for fine needle aspiration (FNA) is needed while evaluating patients with thyroid goiter (JPMA 54:
526;2004).
a primary tumor of over 3 cm in size. One-third had
evidence of metastasis to the lymph nodes. There was ipsi-
lateral cervical lymph node involvement in 60% and bilat-
eral cervical involvement in 20%. Distant metastases to the
lung, bones, brain and distant lymph nodes were present in
19 patients (lungs in 7 patients, bone only in 3 and a combi-
nation of more than one organ involvement in the rest). 
Of the differentiated thyroid cancers originating
from the follicular epithelium, papillary thyroid cancer con-
stituted two thirds and follicular thyroid cancer one third;
40% of the patients with papillary thyroid cancer and 15%
of patients with follicular cancer had local or regional
lymph node involvement. Distant spread at the time of pres-
entation was seen in 9% of papillary and 23% of the follic-
ular cancers (Table).
Anaplastic and poorly differentiated variety com-
prised 7.4% (n = 7). Five of these seven patients had a long
standing goiter, and presented for clinical care when they
developed obstructive symptoms such as dysphagia (2
patients), dyspnea (3 patients) and a superior vena cava syn-
drome (one patient). One other had both dysphagia and
shortness of breath.  
Majority of the patients (76%) underwent at least
one pre-operative diagnostic procedure. This included a fine
needle aspiration cytology (FNAC) in 48 patients, ultra-
sound of the thyroid in 3, technetium scan of the thyroid in
3, CT scan of the neck in 2 and a combination of two or
more procedures in 13 patients.
Lobectomy and isthmusectomy was the preferred
surgical procedure in 32.6% of the patients, followed by
near total thyroidectomy in 30.4%. One-tenth had a subtotal
thyroidectomy. The remainder were not offered thyroid sur-
gery, either due to the advanced nature of the disease or con-
comitant significant comorbid conditions. 
The aggressiveness of the disease did not correlate
with age, sex or histologic subtype. We found no correlation
between the size of the tumor and presence of local inva-
sion, lymph node involvement or distant metastases.  
Discussion
The demographic characteristics of our patients with
thyroid cancer are comparable to western literature, howev-
er clinical presentation is somewhat different and more
aggressive.
Nodular thyroid disease, which encompasses both
solitary nodules of the thyroid and multinodular thyroid
gland, is a fairly common condition. Population based sur-
veys show a prevalence of 4 to 7%9, but ultrasound and
autopsy studies show this prevalence to be close to 50%.10
Thyroid cancer occurs at a frequency of 5 to 6.5 % in nodu-
lar thyroid gland3,4 and is generally detected as part of an
evaluation of solitary thyroid nodule with fine needle aspi-
ration cytology. Solitary nodule of the thyroid was a rela-
tively infrequent mode of presentation in our series.
Majority  (59%) had a nodular goiter that was longstanding
or of recent origin. A series from Riyadh, Saudi Arabia
reports similar findings of nodular goiter as the most fre-
quent presentation in patients with differentiated thyroid
cancer. It was present in three-quarters of their patients.7
This difference in the mode of presentation is multifactori-
al. Given the relatively expensive cost of medical care,
which in most instances is borne directly by the patient, thy-
roid nodules and goiters are often left uninvestigated, until
they become symptomatic (i.e., patients either develop
obstructive symptoms, or develop hyperfunction), enlarge
rapidly, or cause considerable cosmetic disfigurement. This
is compounded by the misconception among health care
professionals that multinodular goiters are caused by iodine
insufficiency and usually remain benign, and are therefore
incapable of neoplastic transformation. It has been proven
that the prevalence of thyroid cancer is similar in multin-
odular goiters as it is for solitary thyroid nodules.11,12 
Figure. Symptoms at presentation.
Table. Frequency of metastasis in differentiated thyroid cancer.
Type of differentiated Local metastases Distant metastases    
cancer (# of patients) No. of patients (%) No. of patients (%)
Papillary thyroid cancer 25 (40 %) 5 (9%)
(55)
Follicular thyroid cancer 5 (15%) 7 (23%)
(30)
The histopathologic distribution of differentiated
thyroid cancer is comparable to international literature, and
has been reported previously from Pakistan by other
authors.6 Series from iodine deficient regions report a rela-
tively higher frequency of thyroid cancer. This trend is vis-
ible in our group of patients, and though only a small per-
centage originates from the northern iodine deficient parts
of Pakistan13, majority has multinodular goiters. There was
a relatively higher proportion of patients who had poorly
differentiated or anaplastic thyroid carcinoma. 
Papillary thyroid cancer (PTC) has a propensity to
metastasize through lymphatics as apposed to follicular thy-
roid cancer (FTC) which spreads through blood vessels.
Mayo clinic series showed that 38% of patients with papil-
lary thyroid cancer present with nodal involvement, com-
pared with 5% of those with follicular.15 One to 7% of PTC
patients have distant metastases diagnosed before or within
30 days of primary treatment compared to 5 to 20 % of FTC
patients. Our data though comparable for local spread,
shows a more aggressive disease in terms of distant metas-
tases. This could be related to larger size of the primary
lesion, or late presentation when the disease has already
advanced.
An appropriate work-up was offered to majority of
the patients with FNAC being the pre-operative procedure
of choice, used either alone or in combination with other
pre-operative imaging studies. There seems to be no prefer-
ence for either  lobectomy/isthmusectomy  or total thy-
roidectomy, as both procedures were used with similar fre-
quency.
Majority of the cases of thyroid cancer in Pakistan
present as multinodular goiters rather than as solitary thy-
roid nodules. A higher percentage of these patients have dis-
tant metastases at the time of presentation to medical care,
thereby reducing the chances of favorable outcome. The
perception amongst the heath care professional that multin-
odular goiter is a benign thyroid disease maybe one reason.
A lower threshold for evaluating nodular thyroid for cancer
is recommended, even if there is a history of long standing
goiter. 
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